QUOTED. 16 October 2019. John Sheridan.
Executive Summary
Abbott signed a deal with Tandem Diabetes Care to develop diabetes solutions combining Abbott's glucose-sensing technology with Tandem's insulin delivery systems. See what Tandem's CEO and president, John Sheridan, said about the partnership here.
"The FDA's new interoperable designations for the various components of automated insulin delivery systems are making integrations of advanced technologies more straightforward, and we are looking forward to exploring these possibilities with Abbott." – John Sheridan, president and CEO, Tandem Diabetes Care
- Find out more: Abbott Inks Partnership With Tandem Diabetes Care
Click here for a free trial of Medtech Insight